Alessandro Perretti is a Medical Doctor with extensive experience in Medical Affairs, particularly in the launch of innovative therapies and vaccines. They began their career with the launch of antiviral treatments for hepatitis C and later led a medical team at GSK to introduce a new Herpes Zoster vaccine. From February 2023 to August 2024, Alessandro served as the Country Medical Lead at Novavax, focusing on R&D in vaccines. Currently, in their role at Biogen, they oversee all medical activities related to the launch of a new treatment for Friedreich’s Ataxia. Their educational background includes a Doctor of Medicine degree from the University of Pavia and a diploma in Acupuncture from Sowen Milano.
This person is not in the org chart
This person is not in any teams
This person is not in any offices